Schedule of Events

View the 2023 Multidisciplinary Thoracic Cancers Symposium faculty and presenters’ disclosure of relationships.

All meeting abstracts were embargoed until Thursday, November 30, at 8:00 a.m. Central time. Once the embargo lifted, all abstracts are available on the online conference planner and digital poster viewing is available in the virtual poster library.

View the 2023 Multidisciplinary Thoracic Symposium abstracts.

View the posters in the Virtual Poster Library.

Wednesday, November 29, 2023
 
4:00 p.m. - 6:00 p.m. Registration
Napoleon Registration Desk
Thursday, November 30, 2023
7:00 a.m. - 4:30 p.m. Registration
Napoleon Registration Desk
7:00 a.m. - 8:00 a.m. Continental Breakfast and Poster Viewing in the Exhibit Hall
Napoleon Ballroom CD
7:50 a.m. - 8:00 a.m. Welcome Address
Napoleon Ballroom AB
Vickie Shannon, MD, MD Anderson Cancer Center, Houston [Pulmonologist]
8:00 a.m. - 8:30 a.m. Major Challenges and Opportunities Facing Us in 2023
Napoleon Ballroom AB
Moderator: Zhongxing Liao, MD, FASTRO, MD Anderson Cancer Center, Houston [R]
  • What Should be the Treatment if Patients Become Unresectable after Neoadjuvant Immunotherapy?
    • Jessica Donington, MD, MSCR, UChicago Medicine, Chicago [S]
  • Resistance for ICI Immunotherapy: Challenges and Opportunities
    • Jianjun Zhang, MD, PhD, MD Anderson Cancer Center, Houston [M]
  • Q&A
8:30 a.m. - 10:00 a.m. The Emerging Benefits of Immunotherapy and Targeted Therapy
Napoleon Ballroom AB
Moderator: Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center, New York [M]
  • Stage I SBRT + Immunotherapy
    • Narek Shaverdian, MD, Memorial Sloan Kettering Cancer Center, New York [R]
  • Phase II iSABR Results
    • Joe Chang, MD, PhD, MS, FASTRO, MD Anderson Cancer Center, Houston [R]
  • ADCs and Bispecific mAbs
    • Sally Lau, MD, NYU Langone Health, Brooklyn, New York [M]
  • Non-TKI Targeted Therapies KRAS, BRAF, and Beyond
    • Jia Luo, Dana-Farber Cancer Center, Boston [M]
  • Q&A
10:00 a.m. - 10:30 a.m. Coffee Break and Poster Viewing in the Exhibit Hall
Napoleon Ballroom CD
10:30 a.m. - 11:30 a.m. Pearls, Pitfalls and Challenges in Toxicities Associated with Immunotherapy and Targeted Therapies: What We Know Now
Napoleon Ballroom AB
Moderator: Vickie Shannon, MD, MD Anderson Cancer Center, Houston [Pulmonologist]
  • Emerging Challenges in Immunotherapy and Targeted Therapy: Combination Therapies, Drug Resistance and Drug Rechallenge, Who? How? When?
    • Abdul Rafeh Naqash, MD, Johns Hopkins University, Baltimore [Professor]
  • Emerging Challenges in Immunotherapy and Targeted Therapy: Lung Toxicity Diagnosis, Risk Factors and Treatment
    • ​Karthik Suresh, MD, Johns Hopkins Medicine, Baltimore [Pulmonologist]
  • Q&A
11:30 a.m. - 12:15 p.m. Modern Substance Use Disorders – ​What's NOT on the Med List?
Napoleon Ballroom AB
Moderator: Linda Martin, MD, MPH, University of Virginia Health Systems, Charlottesville, Virginia [S]
  • Nicotine Addiction, and How to Properly Prescribe Tobacco Cessation Meds
    • ​Matthew Steliga, MD, UAMS Health, Little Rock, Arkansas [S]
  • Non-Rx Drugs - The Good, the Bad and the Ugly  Impact on Cancer Treatments
    • Deepti Behl, MD, Sutter Medical Center, Sacramento, California [M]
  • Panel Discussion and Q&A

Early Detection
Borgne Room
Moderator: Thomas Stinchcombe, MD, Duke Cancer Center, Durham, North Carolina [M]
  • Screening Criteria and Models: Who is Included and Excluded and How to Apply the Current Models
    • Julie Wu, MD, PhD, Stanford University, Palo Alto, California [M]
  • Screening Outside the NLST Patient Population
    • Elaine Shum, MD, NYU Langone Health, New York [M]
  • Blood Based Testing for Screening
    • Aadel Chaudhuri, MD, PhD, Washington University, St. Louis [R]
  • Q&A
12:15 p.m. - 1:30 p.m. Lunch and Poster Viewing in the Exhibit Hall
Napoleon Ballroom CD

Early Career and Trainee Networking Luncheon: Choosing Your Career Path
Borgne Room
  • Aadel Chaudhuri, MD, PhD, Washington University, St. Louis [R]
  • Marina Garassino, MD, University of Chicago Medicine, Chicago [M]
  • Thomas Stinchcombe, MD, Duke Cancer Center, Durham, North Carolina [M]
1:30 p.m. - 3:00 p.m. Plenary Abstract Session
Napoleon Ballroom AB
Moderator: David Carbone, MD, PhD, The Ohio State University, Columbus, Ohio [M]
  • Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)
    • David A. Palma, MD, PhD, Western University, London, Ontario, Canada
    • Discussant: Jeremy Brownstein, MD, MS, The Ohio State University Wexner Medical Center, Columbus, Ohio
  • A Population-Based Analysis of the Management of Symptoms of Depression Among Patients with Stage IV Non-Small Cell Lung Cancer in Ontario, Canada
    • Vivian S. Tan, MD, Western University, London, Ontario, Canada
    • Alan Valentine, MD, FAPOS, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Prognostic Performance of a Genome-Wide Methylome Enrichment Platform in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    • Geoffrey Liu, MD, Princess Margaret Cancer Centre, University Health Network, Ontario, Canada
    • Discussant: Aadel Chaudhuri, MD, PhD, Washington University, St. Louis
  • Lung Cancer Survival Trends in the Veterans Health Administration
    • Drew Moghanaki, MD, MPH, VA Greater Los Angeles Healthcare System, Los Angeles
    • Discussant: Biniam Kidane, MD, MS, University of Manitoba, Manitoba, Canada
3:00 p.m. - 3:30 p.m. Coffee Break and Poster Viewing in the Exhibit Hall
Napoleon Ballroom CD
3:30 p.m. - 4:30 p.m. The Changing Landscape of Lung Cancer Biomarkers
Napoleon Ballroom AB
Moderator: Kurt Schalper, MD, Yale University, New Haven, Connecticut [Surgical Pathologist]
  • Current and Future Biomarkers for Immunotherapy, Targeted Therapies and ADCs in NSCLC
    • Kurt Schalper, MD, Yale University, New Haven, Connecticut [Surgical Pathologist]
  • Molecular Classification and Novel Biomarkers for Small-Cell Lung Cancer
    • Triparna Sen, PhD, Mount Sinai, New York [Professor]
  • Role of Pathologic Response Assessment and Non-Invasive Biomarkers/Liquid Biopsy in Resectable NSCLC
    • Sanja Dacic, MD, PhD, Yale University, New Haven, Connecticut [Pathologist]
  • Role of Digital Pathology and Advanced Computational Analysis/AI in Lung Cancer Management
    • ​Anant Madabhushi, PhD, Emory University, Atlanta [R]
  • Q&A
4:30 p.m. - 5:30 p.m. Networking Reception and Poster Q&A 01 Session in the Exhibit Hall
Napoleon Ballroom CD
Friday, December 1, 2023
7:00 a.m. - 5:00 p.m. Registration Open
Napoleon Registration Deck
7:00 a.m. - 8:00 a.m. Continental Breakfast and Poster Viewing in the Exhibit Hall
Napoleon Ballroom CD
7:55 a.m. - 8:00 a.m. Welcome Address
Napoleon Ballroom AB
Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center, New York [M]
8:00 a.m. - 9:30 a.m. Perioperative and Postoperative Therapies for Resectable Lung Cancer
Napoleon Ballroom AB
Moderator: David Carbone, MD, PhD, The Ohio State University, Columbus, Ohio [M]
  • Targeted and Immunotherapies in Surgically Resectable Non-small Cell Lung Cancer
    • Marina Garassino, MD, University of Chicago Medicine, Chicago [M]
  • Impact of Perioperative Therapies on the Surgical Management of Lung Cancer
    • Neel Chudgar, MD, Montefiore Medical Center, New York [S]
  • The Role of Radiation in Surgically Resectable Lung Cancer
    • Jeremy Brownstein, MD, The Ohio State University, Columbus, Ohio [R]
  • Q&A
9:30 a.m. - 10:00 a.m. Coffee Break and Poster Q&A 02 Session in the Exhibit Hall
Napoleon Ballroom CD
10:00 a.m. - 10:45 a.m. Impact of Frailty and Other Co-Morbidities on Lung Cancer Outcomes
Oak Alley
Moderators: Philip Linden, MD, University Hospitals Cleveland Medical Center, Cleveland [S]
Sue Yom, MD, PhD, FASTRO, UCSF Bakar Precision Medicine Center, San Francisco [R]
  • How to Assess Fitness for Lung Resection
    • Leonidas Tapias, MD, University Hospitals Cleveland Medical Center, Cleveland [S]
  • Comorbidity and Frailty Considerations with Systemic Therapy
    • Mehmet Altan, MD, MD Anderson Cancer Center, Houston [M]
  • Comorbidity and Frailty Considerations with Chemoradiation
    • Pranshu Mohindra, MD, University Hospitals Cleveland Medical Center, Cleveland [R]
  • Q&A
Oligometastatic NSCLC: Current Evidence and Future Directions
Napoleon Ballroom AB
Moderator: Kristin Higgins, MD, Emory University, Atlanta [R]
  • Current Data and Clinical Trials that Will Define the Role in RT in Oligometastatic Disease
    • Daniel Gomez, MD, MBA, Memorial Sloan Kettering Cancer Center, New York {R]
  • Potential Biomarkers for Patient Selection in Oligometastatic Space
    • Puneeth Iyengar, MD, University of Texas Southwestern Medical Center, Dallas [R]
  • Discussion and Q&A
10:45 a.m. - 11:45 a.m. Finding and Removing Small Nodules – Keeping Up with Technological Advances
Napoleon Ballroom AB
Moderator: Biniam Kidane, MD, MS, University of Manitoba, Winnipeg, Manitoba, Canada [S]
  • The State of Evidence regarding Sublobar Resection for Small Early-Stage Lung Cancer
    • ​Anna McGuire, MD, MSc, FRCSC, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada [S]
  • Robotic Bronchoscopy and Navigational Bronchoscopy to Find Small Nodules
    • Otis Rickman, DO, Ascension St. Thomas Hospital Midtown, Nashville, Tennessee [Professor]
  • Molecular Localization of Lung Nodules
    • ​Doraid Jarrar, MD, FACS, FCCP, Penn Medicine, Philadelphia [S]
    Q&A
11:45 a.m. - 1:00 p.m. Lunch and Poster Viewing in the Exhibit Hall
Napoleon Ballroom CD

Early Career and Trainee Networking Luncheon: Launching Your Successful Career
Borgne Room
  • David Carbone, MD, PhD, The Ohio State University, Columbus, Ohio [M]
  • Jamie Chaft, MD, Memorial Sloan Kettering Cancer Center, New York [M]
  • Puneeth Iyengar, MD, University of Texas Southwestern Medical Center, Dallas [R]
  • Quynh-Nhu Nguyen, MD, MD Anderson Cancer Center, Houston [R]
1:00 p.m. - 2:15 p.m. Oral Abstract Session
Napoleon Ballroom AB
Moderator: Zhongxing Liao, MD, FASTRO, MD Anderson Cancer Center, Houston [R]
  • KontRASt-01 Update: Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)
    • Marcelo Negrao, MD, MD Anderson Cancer Center, Houston
  • Dose-volume Predictors of Radiation Pneumonitis Following Thoracic Hypofractionated Radiotherapy
    • Alexander Sasse, Yale School of Medicine, New Haven, Connecticut
  • Esophagitis Following Intensity-Modulated Radiotherapy for Lung Cancer
    • Nathaniel Miller, MD, Virginia Commonwealth University, Richmond
  • Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis
    • Tian Xiao, MD, Western University, Ontario, Canada
  • Clinical, Quality of Life and Cost Outcomes in Patients with Early Stage Non-small Cell Lung Cancer Undergoing Surgery or SBRT
    • Sowmy Thuppal, MD, PhD, Southern Illinois University, Springfield, Illinois
  • Disparities in Delivery of Local-consolidative Surgery for Patients with Single-site Oligometastatic Non-small Cell Lung Cancer
    • Jorge Humberto Rodriguez-Quintero, MD, Montefiore Medical Center, Bronx, New York
  • Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the Thorax
    • Alexander Sasse, Yale School of Medicine, New Haven, Connecticut
2:15 p.m. - 2:45 p.m. Coffee Break and Poster Q&A 03 Session in the Exhibit Hall
Napoleon Ballroom CD
2:45 p.m. - 4:00 p.m. Review/Update on Thymic Malignancy and Mesothelioma
Napoleon Ballroom AB
Moderator: Stephen Chun, MD, MD Anderson Cancer Center, Houston [R]
  • Surgical Considerations in Resectability for Mesothelioma and Thymic Tumors
    • ​Andrea Wolf, MD, Mount Sinai, New York [S]
  • Postoperative Radiotherapy Field Design for Mesothelioma and Thymic Tumors
    • Quynh-Nhu Nguyen, MD, MD Anderson Cancer Center, Houston [R]
    Systemic Therapy Updates for Mesothelioma and Thymic Tumors
    • ​Matthew Gubens, MD, MS, University of California, San Francisco [M]
  • Q&A
4:00 p.m. - 5:00 p.m. Novel Approaches in Limited Stage and Extensive Stage Small Cell Lung Cancer
Napoleon Ballroom AB
Moderator: Percy Lee, MD, FASTRO, City of Hope, Irvine, California [R]
  • Molecular Subclassification and Implications in SCLC Personalized Therapy
    • Jyoti Malhotra, MD, MPH, City of Hope, Irvine, California [M]
  • Novel Advances in Radiotherapy for SCLC
    • Kristin Higgins, MD, Emory University, Atlanta [R]
  • Role of Brain Directed Radiotherapy for SCLC in 2023
    • ​Vinai Gondi, MD, Northwestern Medicine Cancer Center, Warrenville, Illinois [R]
  • Q&A
Saturday, December 2, 2023
7:00 a.m. - 12:15 p.m. Registration Open
Napoleon Registration Desk
7:00 a.m. - 8:00 a.m. Continental Breakfast
Napoleon Ballroom CD
7:55 a.m. - 8:00 a.m. Welcome Address
Napoleon Ballroom AB
Linda Martin, MD, MPH, University of Virginia Health Systems, Charlottesville, Virginia [S]
8:00 a.m. - 9:30 a.m. Stage III: Innovation on the "Big Stage"
Napoleon Ballroom AB
Moderator: Sue Yom, MD, PhD, FASTRO, UCSF Bakar Precision Medicine Center, San Francisco [R]
  • Neoadjuvant Therapy for Resectable Stage III
    • Linda Martin, MD, MPH, University of Virginia Health Systems, Charlottesville, Virginia [S]
  • Adjuvant Therapy for Resectable Stage III
    • Salma Jabbour, MD, FASTRO, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey [R]
  • Immunotherapy in Unresectable Stage III
    • Steven Lin, MD, PhD, MD Anderson Cancer Center, Houston [R]
  • Targeted Therapy in Unresectable Stage III
    • Carl Gay, MD, PhD, MD Anderson Cancer Center, Houston [M]
  • Q&A
9:30 a.m. - 10:30 a.m. Sexual Health and Fertility Preservation under Psychosocial Oncology
Napoleon Ballroom AB
Moderator: Kristin Rojas, MD, FACS, University of Miami Health System, Miami [S]

Speaker: Terri Woodard, MD, MD Anderson Cancer Center, Houston [Professor]
10:30 a.m. - 10:45 a.m. Coffee Break
Napoleon Ballroom CD
10:45 a.m. - 11:45 a.m. Difficult Discussions – Prognosis, Therapeutic Choices, End of Life
Napoleon Ballroom AB
Moderator: Madison Grogan, MPH, The Ohio State University, Columbus, Ohio [M]
  • Discussing Phase I Clinical Trials with Patients with Advanced NSCLC: Challenges and Opportunities
    • Jennifer Carlisle, MD, Emory University, Atlanta [M]
  • Tools to Improve Communication between Physicians and Patients
    • Kate Schueller, MD, University of Wisconsin, Madison, Wisconsin [M]
  • Integration of Early Palliative Care to Improve Outcomes in Patients with NSCLC
    • ​Madison Grogan, MPH, The Ohio State University, Columbus, Ohio [M]
  • Financial Toxicity
    • Meera Ragavan, MD, Kaiser Permanente, San Francisco [M]
  • Q&A
11:45 a.m. - 12:00 p.m. Symposium Key Takeaways and What's Coming Down the Pipeline
Sue Yom, MD, PhD, FASTRO, UCSF Bakar Precision Medicine Center, San Francisco [R]

CO-SPONSORS

TERMS OF USE & PRIVACY POLICY

 

Connect With Us: